IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
Clinical trial NCT07025889 · RECRUITING
Trial details
- NCT number
- NCT07025889
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-02
- Primary completion
- 2027-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.